Erratum: Randomization and baseline transmission in vaccine field trials (Epidemiolody and Infection vol. 135 (181-194) 10.1017/S0950268806006716);Randomization and baseline transmission in vaccine field trials

Epidemiology and Infection

Volumn 135, Issue 2, 2007, Pages 181-194

  Struchiner, C J ^a   Halloran, M E ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COVARIANCE; DISEASE TRANSMISSION; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; INFECTION; INTERMETHOD COMPARISON; NONHUMAN; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STOCHASTIC MODEL; TREATMENT OUTCOME;

EID: 33847325741     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268807008618     Document Type: Erratum

References (37)

1. Smith PG, Morrow RH, eds. Methods for Field Trials of Interventions Against Tropical Diseases: A Toolbox. Oxford: Oxford University Press, 1991.
2. Efron B. Forcing a sequential experiment to be balanced. Biometrika 1971; 58: 403-417.
3. Greenland S, Robins JM. Identifiability, exchangeability, and epidemiologic confounding. International Journal of Epidemiology 1986; 15: 412-418.
4. Greenland S. Interpretation and choice of effect measures in epidemiologic analyses. American Journal of Epidemiology 1987; 125,: 761-768.
5. Gail MH. Adjusting for covariates that have the same distribution in exposed and unexposed cohorts. In Moolgavkar SH, Prentice RL, eds. Modern Statistical Methods, New York: Wiley, 1986, pp. 3-18.
6. Gail MH. The effect of poofing across strata in perfectly balanced studies. Biometrics 1988; 44: 151-162.
7. Gail MH, Tan WY, Piantadosi S. The effect of omitting covariates on tests for no treatment effect in randomized clinical trials. Biometrika 1988; 75: 57-64.
8. Gail MH, Wieand S, Piantadosi S. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates. Biometrika 1984; 71: 431-444.
9. Halloran ME, Struchiner CJ. Causal inference for infectious diseases. Epidemiology 1995; 6: 142-151.
10. Fine PEM, Clarkson JA, Miller E. The efficacy of pertussis vaccines under conditions of household exposure: Further analysis of the 1978-80 PHLS-ERL study in 21 area health authorities in England. International Journal of Epidemiology 1998; 17: 635-642.
11. Halloran ME, Préziosi M-P, Chu H. Estimating vaccine efficacy from secondary attack rates. Journal of the American Statistical Association 2003; 98: 38-46.
12. Halloran ME, Longini IM, Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiologic Reviews 1999; 21: 73-88.
13. Halloran ME, et al. Direct and indirect effects in vaccine field efficacy and effectiveness. American Journal of Epidemiology 1991; 133: 323-331.
14. Struchiner CJ, et al. Malaria vaccines: Lessons from field trials. Cadernos de Saúde Pública 1994; 10 (Suppl. 2): 310-326.
15. Rubin DB. Bayesian inference for causal effects: The role of randomization. Annals of Statistics 1978; 7: 34-58.
16. Greenwood M, Yule UG. The Statistics of anti-typhoid anti-cholera inoculations, and the interpretation of such statistics in general. Proceedings of the Royal Society Medicine 1915; 8: 113-194.
17. Rubin DB. Discussion of 'Randomization analysis of experimental data in the Fisher randomization test' by Basu. Journal of the American Statistical Association 1980; 75: 591-593.
18. Greenland S. Absence of confounding does not correspond to collapsibility of the rate ratio or rate difference. Epidemiology 1996; 7: 498-501.
19. Greenland S. Confounding in epidemiologic studies. Biometrics 1984; 45: 1309-1310.
20. Rhodes PH, Halloran ME, Longini IM. Counting process models for differentiating exposure-to infection and susceptibility. Journal of the Royal Statistical Society B 1996; 59: 751-762.
21. Greenland S. Interpretation and estimation of summary ratios under heterogeneity. Statistics in Medicine 1982; 1: 217-227.
22. Noya O, et al. A population-based clinical trial with the SPf66 synthetic P. falciparum malaria vaccine in Venezuela. Journal of Infectious Diseases 1994; 170: 396-402.
23. Valero MV, et al. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparun malaria in Colombia. Lancet 1993; 341: 705-710.
24. D'Alessandro U, et al. Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 1995; 346: 462-467.
25. Lindley DV, Novick MR. The role of exchangeability in inference. Annals of Statistics 1981; 9: 45-58.
26. Rubin DB. Practical implications of modes of statistical inference for causal effect and the critical role of the assignment mechanism. Biometrics 1991; 47: 1213-1234.
27. Breslow NE, Storer BE. General relative risk functions for case-control studies. American Journal of Epidemiology 1985; 122: 149-162.
28. Brunet RC, Struchiner CJ, Halloran ME. On the distribution of vaccine protection under heterogeneous response. Mathematical Biosciences 1993; 116: 111-125.
29. Halloran ME, Longini IM, Struchiner CJ. Estimability and interpretation of vaccine efficacy using frailty mixing models. American Journal of Epidemiology 1996; 144: 83-97.
30. Longini IM, Halloran ME. A frailty mixture model for estimating vaccine efficacy. Applied Statistics 1996; 45: 163-175.
31. Durham LK, et al. Estimation of vaccine efficacy in the presence of waning: Application to cholera vaccines. American Journal of Epidemiology 1998; 147: 948-959.
32. Kanaan MN, Farrington CP. Estimation of waning vaccine efficacy. Journal of the American Statistical Association 2002; 97: 389-397.
33. Brunet RC, Struchiner CJ. Rate estimation from prevalence information on a simple epidemiologic model for health interventions. Theoretical Population Biology 1996; 50: 209-226.
34. Struchiner CJ, et al. On the use of state-space models for the evaluation of health interventions. Journal of Biological Systems 1995; 3: 851-865.
35. Brunet RC, Struchiner CJ. A non-parametric method for the reconstruction of age- and time-dependent incidence from the prevalence data of irreversible diseases with differential mortality. Theoretical Population Biology 1999; 56: 76-90.
36. Brunet RC, Struchiner CJ. A method for estimating time dependent intervention benefits under arbitrarily varying age and exogenous components of hazard. Lifetime Data Analysis 2001; 7: 377-392.
37. Savage LJ. The Foundations of Statistical Inference. London: Methuen, 1962.